Logos Global Management LP 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 4:27 pm Purchase |
2023-06-26 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Logos Global Management LP | 3,469,927 9.900% |
3,469,927 (New Position) |
Filing |
| 2023-07-18 4:01 pm Purchase |
2023-07-06 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Logos Global Management LP | 254,000 8.100% |
254,000 (New Position) |
Filing |